Xconomy | - Business + Technology in the Exponential Economy

From Amylin Resurrects Obesity Drug, in New Combination with Diabetes Drug Symlin:

amylin1

amylin1—

Amylin is developing drugs for obesity

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.